Metasphere Labs Inc.
LABZF
$0.05
-$0.04-45.46%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.93% | -90.27% | -48.07% | 31.26% | 229.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.93% | -90.27% | -48.07% | 31.26% | 229.71% |
| Cost of Revenue | -99.54% | -85.65% | -36.49% | 23.93% | 215.69% |
| Gross Profit | -99.99% | -91.11% | -50.27% | 32.84% | 232.62% |
| SG&A Expenses | -27.01% | -15.74% | -8.72% | -68.10% | -80.86% |
| Depreciation & Amortization | -- | -62.11% | -47.13% | -61.89% | -67.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -47.64% | -32.53% | -14.49% | -62.15% | -74.66% |
| Operating Income | -221.65% | -211.85% | -580.47% | 102.15% | 112.23% |
| Income Before Tax | -31,109.52% | -347.94% | 64.12% | 93.97% | 99.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31,109.52% | -347.94% | 64.12% | 93.97% | 99.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31,109.52% | -405.11% | 64.05% | 94.02% | 99.98% |
| EBIT | -221.65% | -211.85% | -580.47% | 102.15% | 112.23% |
| EBITDA | -206.16% | -193.94% | -333.57% | 104.65% | 114.42% |
| EPS Basic | -114.77% | 89.00% | 98.10% | 99.89% | 102.15% |
| Normalized Basic EPS | -113.06% | -160.91% | 93.46% | 100.48% | 104.79% |
| EPS Diluted | -120.43% | 87.92% | 97.95% | 99.65% | 101.99% |
| Normalized Diluted EPS | -114.05% | -182.05% | 93.41% | 99.83% | 104.45% |
| Average Basic Shares Outstanding | 79.03% | 143.85% | 554.19% | 1,520.89% | 1,118.23% |
| Average Diluted Shares Outstanding | 35.18% | 65.22% | 364.18% | 1,899.14% | 1,513.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |